‘A little more hope:’ ALS patients taking anti-psychotic drug in clinical trial
CALGARY — Cliff Barr has no illusions about how his life is going to end but he still has hope.
The 70-year-old from Okotoks, Alta., is one of 100 patients taking part in new Canada-wide clinical trial to treat ALS — a debilitating and ultimately deadly neural disease that has few treatments and no cure.
“It is a difficult and an awkward disease,” Barr said Thursday at the University of Calgary, which is running the trial.
“I found the idea of the clinical trial promising. It gives you a little more hope.”